What is the recommended evaluation and management for twins with discordant congenital anomalies or conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Twins with Discordant Congenital Anomalies

For twins discordant for congenital anomalies, establish chorionicity in the first trimester (10-13 weeks) as this single determination dictates all subsequent management decisions, surveillance intensity, and counseling about outcomes. 1

Initial Diagnostic Evaluation

Chorionicity Determination

  • First-trimester ultrasound (10-13 weeks) is the definitive and only reliable method to establish chorionicity and amnionicity—do not infer chorionicity from fetal gender or number of placental masses, as this leads to critical management errors. 2
  • Monochorionic (MC) twins account for ~20% of twin pregnancies but represent ~30% of complications, with overall perinatal mortality of ~10%. 2

Anomaly Detection and Characterization

  • Detailed first-trimester ultrasound (12-13 weeks) can detect structural abnormalities in 27.3% of twin pregnancies; anomalies most commonly involve the cranial vault, midline brain, and abdominal wall. 1
  • Monochorionicity and increasing intertwin discrepancy in crown-rump length (CRL) and nuchal translucency (NT) measurements are associated with fetal structural abnormalities. 1
  • Perform comprehensive fetal anatomic survey at 18-22 weeks for all twin pregnancies, as congenital anomalies occur in roughly 1 in 25 dichorionic (DC) pregnancies. 1

Genetic and Cardiac Evaluation

  • Sample both fetuses during invasive diagnostic testing even when only one appears at risk—this prevents missed diagnoses in the apparently normal co-twin. 1
  • Twins with increased NT (≥3 mm) or confirmed aneuploidy require detailed second-trimester anatomic survey and fetal echocardiography. 1
  • First-trimester combined screening (including NT at 11-14 weeks) detects >85% of chromosomal abnormalities in DC twins. 1

Surveillance Protocols by Chorionicity

Dichorionic Twins with Discordant Anomalies

  • Schedule routine ultrasound surveillance every 3-4 weeks beginning after the anatomy scan for uncomplicated DC pregnancies. 1
  • At the anatomy scan, obtain transvaginal cervical-length measurement to evaluate preterm-birth risk. 1
  • Screen for vasa previa and velamentous cord insertion, which occur more frequently in multiple gestations. 1
  • If concerns arise regarding fetal growth or anemia, perform appropriate Doppler evaluation. 1

Monochorionic Twins with Discordant Anomalies

  • Initiate ultrasound surveillance every 2 weeks starting at 16 weeks and continue until delivery—MC twins require approximately twice the frequency of scans compared to DC twins. 1, 2
  • Each surveillance visit must include:
    • Maximum vertical pocket (MVP) measurement in each amniotic sac 1, 2
    • Visualization of urine-filled bladder in each fetus 1, 2
    • Umbilical-artery Doppler assessment 1, 2
    • Middle cerebral artery peak-systolic velocity (MCA-PSV) Doppler to screen for twin anemia-polycythemia sequence (TAPS) 1, 2
  • Increase surveillance frequency immediately when complications arise (cervical shortening, growth disturbance, abnormal amniotic fluid). 1

Management Options and Outcomes

Expectant Management

  • In monochorionic twins with discordant structural anomalies managed expectantly (excluding TTTS, TAPS, TRAP, or selective growth restriction), livebirth rate of the healthy co-twin is 82.7%. 3
  • Spontaneous in-utero demise of the anomalous twin occurs in 17.3% of expectantly managed MC cases and is followed by spontaneous demise of the healthy co-twin in 44.4% of these cases. 3
  • Expectant management does not increase risk of premature delivery in twins discordant for major anomalies; median gestational age at delivery is similar to twins without anomalies (254 vs. 257 days). 4
  • In MC twins discordant for anencephaly managed expectantly, 21.1% of anencephalic fetuses die at 20-32 weeks, and in three-quarters of these cases the normal co-twin also dies. 5

Selective Feticide

  • Selective feticide does not significantly alter survival of the healthy co-twin compared to expectant management (88.5% vs. 82.7% livebirth rate). 3
  • In MC twins undergoing selective feticide, 11.5% of healthy co-twins die 5.3 ± 3.1 days after the procedure. 3
  • For dichorionic twins, selective termination before 18 weeks is associated with the lowest pregnancy loss (3.1%) and highest 28-day survival (96.9%); intermediate procedures (18-23 weeks) have lower survival (86%) and higher loss (12%). 6
  • Late selective termination (after 23 weeks) in DC twins achieves 100% survival but carries 27% risk of preterm delivery before 32 weeks. 6

Cord Occlusion for Monochorionic Twins

  • Ultrasound-guided bipolar cord coagulation in MC pregnancies (mostly for TRAP or severe TTTS) achieves 77.2% survival rate with 31.0% early preterm delivery rate. 5
  • For MC twins discordant for anencephaly, it remains uncertain whether expectant management or cord occlusion is superior—both approaches carry substantial risks to the normal co-twin. 5

Delivery Timing Recommendations

Pregnancy Type Recommended Timing Citation
DC twins (uncomplicated) 37-38 weeks [1]
MC twins (uncomplicated) 34-36 weeks [1,2]
MC twins post-selective feticide 34-36 weeks if both survive [2]
MC twins with single fetal demise 39 weeks (full term) unless other indications [1,2]

Critical Management Pitfalls

  • Do not delay referral to a fetal-intervention center when TTTS (stage II-IV) or TAPS (stage II before 32 weeks) develops in MC twins with discordant anomalies—timely intervention improves outcomes. 1, 2
  • Do not rely on umbilical-artery Doppler alone in DC twins without growth restriction; comprehensive assessment is required. 1
  • Do not assume the apparently normal co-twin is genetically normal—a wide spectrum of major discordant structural anomalies can occur in monochorionic pregnancies despite genetic identity, with overall survival of the anomalous twin only 32%. 7
  • In MC twins with discordant anomalies, 26% are complicated by selective intrauterine growth restriction and 5% by TTTS, requiring intensified surveillance protocols. 7
  • Administer a single course of corticosteroids for fetal lung maturation between 24 and 33 6/7 weeks if preterm delivery is anticipated, particularly in pregnancies undergoing invasive fetal procedures. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ultrasound Surveillance and Intervention in Twin Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Expectant management in twin pregnancies with discordant structural fetal anomalies.

Twin research and human genetics : the official journal of the International Society for Twin Studies, 2011

Research

Dilemmas in the management of twins discordant for anencephaly diagnosed at 11 + 0 to 13 + 6 weeks of gestation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2006

Research

Major Discordant Structural Anomalies in Monochorionic Twins: Spectrum and Outcomes.

Twin research and human genetics : the official journal of the International Society for Twin Studies, 2018

Guideline

Management of Monochorionic Twin Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.